BALVERSA FILM-COATED TABLETS 3MG

Product Information

Registration Status: Active

BALVERSA FILM-COATED TABLETS 3MG is approved to be sold in Singapore with effective from 2020-08-07. It is marketed by JOHNSON & JOHNSON PTE LTD, with the registration number of SIN15986P.

This product contains Erdafitinib 3.00 mg in the form of TABLET, FILM COATED. It is approved for ORAL use.

This product is manufactured by Janssen Cilag SpA in ITALY.

It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.

Erdafitinib

Description

Erdafitinib has been used in trials studying the basic science and treatment of Tumor or Lymphoma.

Active Ingredient/Synonyms

Erdafitinib | Erdafitinib |


Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.

References

  1. Health Science Authority of Singapore - Reclassified POM
  2. Drugbank